Currently, most researchers in the field believe that although MOG-ON is similar to AQP4-ON in clinical manifestations, unlike AQP4-ON, MOG-ON is not an immune subtype of neuromyelitis optica spectrum disorder (NMOSD), but a subtype of MOG antibody-related diseases (MOGAD) (19). Here, AQP4 is linked to neuromyelitis optica.